Wondering when to consider JAK inhibitors? We’ve got just the expert. This week, we’re joined by Dr. Jason Hawkes as he outlines just when clinicians should consider implementing JAK inhibitors. Listen in as he talks about the many factors of JAK inhibitor treatments and practical tips for counseling patients on systemic therapies. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.

Jason Hawkes, MD MS is a board-certified dermatologist in the greater Sacramento area. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program’s 2+2 dermatology research track. Dr. Hawkes then worked as a medical dermatologist as a faculty member in the Departments of Dermatology at the University of Utah, Icahn School of Medicine at Mount Sinai, and University of California Davis. In addition to being a board-certified dermatologist, he completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master’s degree in Clinical Investigation from Rockefeller University in NYC.   Dr. Hawkes is currently serving on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF), as well as his role as Councilor in the International Psoriasis Council (IPC). He is the recipient of multiple research grants and teaching awards, including the 2021 NPF Outstanding Educator in Psoriatic Disease. He has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 60 peer-reviewed publications and 10 book chapters. Dr. Hawkes’ principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel systemic or biologic therapies.   To learn more about the Interaction of the Immune and Digestive Systems in the Context of Skin Disease, attend Dr. Hawkes' lecture at the 2023 Integrative Dermatology Symposium and earn CME credits online with the LearnSkin Examining the Role of New and Emerging Therapies for the Treatment of Atopic Dermatitis Series.   Supported by an independent educational grant from Pfizer.